| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |